![](https://weeklysauce.com/wp-content/uploads/2021/11/image-2655748553.jpg)
The first human clinical trial of a nasal vaccine to slow the progression of Alzheimer’s disease is set to begin after nearly 20 years of research. This is a “remarkable milestone,” according to Dr. Howard Weiner, co-director of the Ann Romney Center for Neurologic Diseases at Brigham and Women’s Hospital in Boston. “Over the last… read on > read on >